ATRIUM MEDICAL CORPORATION RECEIVES FDA APPROVAL FOR THE IVENA VASCULAR PATCH

Medical Corporation announced that it has received U.S. FDA 510K marketing clearance for a new vascular implant device called the iVENA Vascular Patch. Indicated for use in the surgical repair and closure of the vascular system, Atrium's latest implant technology is an extremely thin, reinforced biomaterial that suggests unsurpassed surgical installation convenience, reduced blood loss and handling efficiency.

Yahoo News (http://biz.yahoo.com/prnews/060830/new002.html?.v=70)